Antibiotic prophylaxis in ureteroscopy-time for a good quality randomised controlled trial?

World J Urol. 2021 Jul;39(7):2809-2810. doi: 10.1007/s00345-020-03252-6. Epub 2020 May 18.

Authors

Dinul Hettiarachchi¹, Alistair Rogers², Rajan Veeratterapillay², Chris Harding²

Affiliations

¹ The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. [email protected].
² Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.

PMID: 32424514
DOI: 10.1007/s00345-020-03252-6

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis*
Antimicrobial Stewardship
Bacterial Infections / etiology
Bacterial Infections / prevention & control*
Drug Resistance, Bacterial
Humans
Randomized Controlled Trials as Topic
Ureteroscopy / adverse effects*
Ureteroscopy / instrumentation
Ureteroscopy / methods
Urologic Diseases / diagnosis
Urologic Diseases / surgery

Substances

Anti-Bacterial Agents